Pharmaceutical Executive
Pharmaceutical Executive-06-01-2018
Volume: 38
Issue: 6
Pharmaceutical Executive-05-01-2018
Volume: 38
Issue: 5
Pharmaceutical Executive-04-01-2018
Volume: 38
Issue: 4
Pharmaceutical Executive-03-01-2018
Volume: 38
Issue: 3
Pharmaceutical Executive-02-01-2018
Volume: 38
Issue: 2
Pharmaceutical Executive-01-01-2018
Volume: 38
Issue: 1
Pharmaceutical Executive-12-01-2017
Volume: 37
Issue: 12
Pharmaceutical Executive-11-01-2017
Volume: 37
Issue: 11
Pharmaceutical Executive-10-01-2017
Volume: 37
Issue: 10
Pharmaceutical Executive-09-01-2017
Volume: 37
Issue: 9
Pharmaceutical Executive-08-01-2017
Volume: 37
Issue: 8
Pharmaceutical Executive-07-01-2017
Volume: 37
Issue: 7
Pharmaceutical Executive-06-01-2017
Volume: 37
Issue: 6
Pharmaceutical Executive-05-01-2017
Volume: 37
Issue: 5
Pharmaceutical Executive-04-01-2017
Volume: 37
Issue: 4
Pharmaceutical Executive-03-01-2017
Volume: 37
Issue: 3
Pharmaceutical Executive-02-01-2017
Volume: 37
Issue: 2
Pharmaceutical Executive-01-01-2017
Volume: 37
Issue: 1
Pharmaceutical Executive-12-01-2016
Volume: 36
Issue: 12
Pharmaceutical Executive-11-01-2016
Volume: 36
Issue: 11
Pharmaceutical Executive-10-01-2016
Volume: 36
Issue: 10
Pharmaceutical Executive-09-01-2016
Volume: 36
Issue: 9
Pharmaceutical Executive-08-01-2016
Volume: 36
Issue: 8
Pharmaceutical Executive-07-01-2016
Volume: 36
Issue: 7
Pharmaceutical Executive-06-01-2016
Volume: 36
Issue: 6
Pharmaceutical Executive-05-01-2016
Volume: 36
Issue: 5
Pharmaceutical Executive-04-01-2016
Volume: 36
Issue: 4
Pharmaceutical Executive-03-01-2016
Volume: 36
Issue: 3
Pharmaceutical Executive-02-01-2016
Volume: 36
Issue: 2
Pharmaceutical Executive-01-01-2016
Volume: 36
Issue: 1
Advertisement
Advertisement
Trending on PharmExec
1
FDA’s Advisory Panel Votes in Favor of Updating Covid-19 Vaccine Shots to Target XFG Variant
2
CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo
3
WHO Prioritizes Three Experimental Treatments for Bundibugyo Ebola Strain
4
FDA's Timeline for DTC Prescription Drug Ad Oversight
5